Legislative Activity

This resolution expresses support for designating July 15, 2026, as Glioblastoma Awareness Day. It aims to raise public awareness about glioblastoma, the most aggressive malignant brain tumor, and honor those affected by the disease. The bill encourages greater investment in research and collaboration to develop improved treatments and outcomes for patients.

This bill amends the House of Representatives' rules to prohibit Members, officers, and employees from participating in certain prediction markets involving excluded commodities. The legislation aims to prevent conflicts of interest by banning trades tied to the outcome of specific events. It also expresses the sense of the House that the executive and judicial branches should adopt similar restrictions.

This bill directs the President to withdraw U.S. Armed Forces from hostilities involving Iran, unless those forces are necessary for imminent self-defense or the defense of an ally. The removal must comply with the War Powers Resolution reporting requirements. This directive ceases if Congress issues a formal declaration of war or specific authorization for military force against Iran.

The Baltic Security Assessment Act of 2025 affirms the critical importance of Estonia, Latvia, and Lithuania to U.S. national security amidst Russian aggression. This bill mandates that the Secretary of State and Secretary of Defense deliver a comprehensive report to Congress detailing emerging military, cyber, and political threats to the Baltic states. The report must also recommend specific actions to enhance U.S. and NATO defense cooperation and bolster Baltic resilience.

The Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 mandates that Medicare Part D plans prioritize lower-cost generic and biosimilar drugs on their formularies starting in 2027. By requiring these medications to be placed in preferred tiers and prohibiting restrictive access barriers, the bill aims to reduce out-of-pocket costs for seniors.

The GUARDRAILS Act repeals the December 11, 2025, Executive Order regarding national AI policy. This legislation prohibits the use of federal funds to implement or enforce the mandates set forth in that order.

The Momnibus Act is a comprehensive legislative package designed to end preventable maternal mortality and close racial and ethnic disparities in maternal health outcomes. By addressing social determinants of health, expanding nutritional and mental health support, and investing in a diverse, culturally competent workforce, the bill provides a holistic framework for improving care. Through targeted federal grants, enhanced data collection, and innovative technology, the Act aims to ensure that all pregnant and postpartum individuals receive the equitable, high-quality care they deserve.

The Enhanced Iran Sanctions Act of 2025 strengthens U.S. policy by imposing mandatory sanctions on foreign persons and financial institutions that support Iran’s nuclear, ballistic missile, drone, and terrorist activities. The bill specifically targets Iran’s petroleum and petrochemical sectors to cut off funding for these malign programs. Additionally, it expands the State Department’s "Rewards for Justice" program to incentivize the reporting of individuals who evade these sanctions.

The AI-Ready Bio-Data Standards Act directs the National Institute of Standards and Technology (NIST) to establish standardized frameworks and definitions for biological research data. These measures aim to ensure that federally funded biological datasets are structured and accessible for effective use in artificial intelligence training and biotechnology research. The bill also mandates the creation of public repositories and advisory groups to support federal agencies and researchers in implementing these standards.

The Medicaid VBPs for Patients (MVP) Act updates federal drug pricing regulations to formally support value-based purchasing arrangements in Medicaid and Medicare. By refining how drug prices are calculated and providing guidance for state-level implementation, the bill aims to improve patient access to innovative therapies while ensuring better health outcomes. Additionally, it creates necessary legal exceptions for these arrangements and mandates a GAO study to evaluate their long-term impact on costs and patient care.

The America’s Living Library Act establishes a pilot program within the Department of the Interior to collect, sequence, and create a public database of genomic data from plants, animals, fungi, and microbes in national parks. This initiative mandates coordination across federal agencies for sample collection, long-term physical storage, and data integration with existing scientific systems. The bill authorizes specific funding for the project and supporting agencies through fiscal year 2031, with the program terminating ten years after enactment.

The Democracy Is Strengthened by Casting Light On Spending in Elections Act of 2026 aims to increase transparency and security in U.S. elections. It closes loopholes to ban foreign national spending in elections, mandates disclosure for "dark money" political spending, and requires clear funding disclosures on political ads. The bill also centralizes legal challenges to campaign finance laws in Washington, D.C., for faster resolution.

The Cloud LAB Act of 2026 establishes a national pilot program to create a network of automated, remotely operated biotechnology laboratories. By funding these "cloud laboratories," the initiative aims to accelerate research, generate high-quality biological data for artificial intelligence training, and provide scientists with secure, centralized access to advanced experimental tools.

The Iran Human Rights, Internet Freedom, and Accountability Act of 2026 aims to support the Iranian people by expanding access to uncensored internet and communication technologies. The bill strengthens U.S. policy against regime repression by mandating investigations into human rights abuses and establishing a new Treasury initiative to combat corruption and money laundering by Iranian officials. Additionally, it enhances congressional oversight of sanctions and promotes independent media to counter state-sponsored censorship.

The Federal Extreme Risk Protection Order Act of 2026 establishes a federal process for issuing Extreme Risk Protection Orders (ERPOs) that temporarily prohibit individuals deemed a danger from possessing firearms. The bill allows family members or law enforcement to petition federal courts for temporary or long-term orders based on evidence of imminent risk of harm. Furthermore, it creates a federal grant program to incentivize and support states and tribes in implementing their own qualifying ERPO laws. Finally, it mandates that individuals subject to these federal orders surrender their firearms and ensures these orders are recognized across state lines.

The Secure Firearm Storage and Suicide Prevention Act of 2026 aims to reduce firearm-related injuries and suicides, particularly among youth. It directs the Secretary of Education to develop national best practices for secure firearm storage and suicide prevention education. Local educational agencies must then create and distribute tailored guidance incorporating these federal standards to students and parents annually.

This bill provides the funding and establishes the operational rules for the Department of Homeland Security (DHS) for Fiscal Year 2026 across all major components, including intelligence, security operations, emergency management, and research. It allocates billions for agencies like TSA, Coast Guard, FEMA, and CISA while imposing strict new requirements for congressional oversight, spending transparency, and management of federal grants. The legislation also includes specific policy directives, such as mandating security screening for senior officials and restricting certain intelligence and contracting activities.

The Firearm Safety Act of 2025 removes the existing exclusion for firearms under the Consumer Product Safety Act. This action subjects firearms to regulation by the Consumer Product Safety Commission (CPSC) as consumer products.

This resolution expresses support for designating a specific day as Barth Syndrome Awareness Day to raise public awareness of this rare genetic disorder. The goal is to encourage early diagnosis, advance research, and support the development of new treatments and cures for Barth syndrome.

The Community Health Center Drug Pricing Protection Act ensures that Federally-qualified health centers (FQHCs) receive the full 340B discounted price for drugs at the point of purchase. This legislation prohibits manufacturers from requiring FQHCs to pay more than the established ceiling price upfront, regardless of any later rebates or reimbursements. The goal is to guarantee immediate, upfront savings for these vital health centers.